List of conditions treated with hematopoietic stem cell transplantation
Hematopoietic stem cell transplantation may be used to treat a number of conditions both congenital and acquired.
Acquired
-  Malignancies
-  Hematological
-  Leukemias
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Chronic lymphocytic leukemia (CLL)
- Chronic myelogenous leukemia (CML), accelerated phase or blast crisis
 
- Lymphomas
-  Myelomas
- Multiple myeloma (Kahler's disease)
 
 
-  Leukemias
- Solid tumor cancers
 
-  Hematological
-  Hematologic disease
- Phagocyte disorders
-  Anemias
- Paroxysmal nocturnal hemoglobinuria (PNH; severe aplasia)
- Aplastic anemia
- Acquired pure red cell aplasia
 
- Myeloproliferative disorders
 
-  Metabolic disorders
-  Amyloidoses
- Amyloid light chain (AL) amyloidosis
 
 
-  Amyloidoses
- Environmentally-induced diseases
- Viral diseases
Congenital
-  Lysosomal storage disorders
-  Lipidoses (disorders of lipid storage)
-  Neuronal ceroid lipofuscinoses
- Infantile neuronal ceroid lipofuscinosis (INCL, Santavuori disease,)
- Jansky-Bielschowsky disease (late infantile neuronal ceroid lipofuscinosis)
 
- Sphingolipidoses
- Leukodystrophies
- Adrenoleukodystrophy
- Metachromatic leukodystrophy
- Krabbe disease (globoid cell leukodystrophy)
 
 
-  Neuronal ceroid lipofuscinoses
-  Mucopolysaccharidoses
- Hurler syndrome (MPS I H, α-L-iduronidase deficiency)
- Scheie syndrome (MPS I S)
- Hurler-Scheie syndrome (MPS I H-S)
- Hunter syndrome (MPS II, iduronidase sulfate deficiency)
- Sanfilippo syndrome (MPS III)
- Morquio syndrome (MPS IV)
- Maroteaux-Lamy syndrome (MPS VI)
- Sly syndrome (MPS VII)
 
 
-  Glycoproteinoses
- Mucolipidosis II (I-cell disease)
- Fucosidosis
- Aspartylglucosaminuria
- Alpha-mannosidosis
 
 
-  Other
- Wolman disease (acid lipase deficiency)
 
 
 
-  Lipidoses (disorders of lipid storage)
-  Immunodeficiencies
- T-cell deficiencies
-  Combined T- and B-cell deficiencies
- Severe combined immunodeficiency (SCID), all types
 
- Well-defined syndromes
- Phagocyte disorders
-  Immune dysregulation diseases
- Griscelli syndrome, type II
 
-  Innate immune deficiencies
- NF-Kappa-B Essential Modulator (NEMO) deficiency (Inhibitor of Kappa Light Polypeptide Gene Enhancer in B Cells Gamma Kinase deficiency)
 
 
-  Hematologic diseases
- Hemoglobinopathies
- Sickle cell disease
- β thalassemia major (Cooley's anemia)
 
- Anemias
- Cytopenias
- Hemophagocytic syndromes
 
References
- ↑ Hütter G, Nowak D, Mossner M, Ganepola S, Müßig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, Blau IW, Hofmann WK and Thiel E (2009). "Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation". N Engl J Med 360 (7): 692–698. doi:10.1056/NEJMoa0802905. PMID 19213682.
This article is issued from Wikipedia - version of the Thursday, March 21, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.